A possible mechanism underlying HPR when receiving aspirin in patients with diabetes might be a faster recovery of platelet COX1 activity leading to incomplete thromboxane inhibition during the 24-h dosing interval. The gene discussed is PTGS1; the disease is diabetes mellitus.